6AQQ
Crystal structure of Staphylococcus aureus biotin protein ligase in complex with inhibitor
6AQQ の概要
| エントリーDOI | 10.2210/pdb6aqq/pdb |
| 分子名称 | Bifunctional ligase/repressor BirA, (3aS,4S,6aR)-4-(5-{1-[(3-fluorophenyl)methyl]-1H-1,2,3-triazol-4-yl}pentyl)tetrahydro-1H-thieno[3,4-d]imidazol-2(3H)-one (3 entities in total) |
| 機能のキーワード | antibiotic, inhibitor, ligase |
| 由来する生物種 | Staphylococcus aureus |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 38404.33 |
| 構造登録者 | |
| 主引用文献 | Paparella, A.S.,Lee, K.J.,Hayes, A.J.,Feng, J.,Feng, Z.,Cini, D.,Deshmukh, S.,Booker, G.W.,Wilce, M.C.J.,Polyak, S.W.,Abell, A.D. Halogenation of Biotin Protein Ligase Inhibitors Improves Whole Cell Activity against Staphylococcus aureus. ACS Infect Dis, 4:175-184, 2018 Cited by PubMed Abstract: We report the synthesis and evaluation of 5-halogenated-1,2,3-triazoles as inhibitors of biotin protein ligase from Staphylococcus aureus. The halogenated compounds exhibit significantly improved antibacterial activity over their nonhalogenated counterparts. Importantly, the 5-fluoro-1,2,3-triazole compound 4c displays antibacterial activity against S. aureus ATCC49775 with a minimum inhibitory concentration (MIC) of 8 μg/mL. PubMed: 29131575DOI: 10.1021/acsinfecdis.7b00134 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.71 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






